LITS logo

LITE STRATEGY INC

LITSNASDAQ
🏆 #4495 by market capEarnings Nov 5US Equity
$301.64▲ $13.94 (+4.62%)
Simulated price
🔔
Track LITS
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 4.6%
7d▲ 22926.0%
14d▲ 27829.6%
30d▲ 30993.7%
ytd▲ 22410.4%
1y▲ 11775.6%
🏦Market Cap
$45M
Small Cap
📈Revenue Growth (YoY)
-100.0%
Declining
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
68
Fair

Trading Snapshot

Day Range
$297.21 – $303.56
52-Week Range
$0.69 – $2.97
Volume
$5.68B
Avg Volume
$6.25B
Shares Outstanding
34.0M
Next Earnings
Nov 14, 2026

Fundamentals Snapshot

Annual Revenue
$8M
Last Q Revenue
$2M
P/E Ratio
-0.1
P/S Ratio
0.0x
EPS (TTM)
$-9.13
Dividend Yield
0.00%
Dilution (1yr)
+0.0%

Why Investors Own LITS

  • ✓High-growth profile — revenue up +21.1% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 39% gross margin and 13% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

LITS logo

LITE STRATEGY INC

LITS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▼ −100.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
100.0%▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$17M▼ −220.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$21M▼ −58.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
6.7M▲ +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$9M▼ −$15M YoY
StockOtter · stockotter.space

About LITE STRATEGY INC

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
68/100

Analyst Price Target

ⓘ
Average Target
$368.86
▲ +22.3% Upside
High Target$435.14
Low Target$342.82
Based on 19 analysts

Latest News & Updates

🚀
CNBC·2h ago

LITE STRATEGY INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift LITS price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

LITE STRATEGY INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.